Insmed Incorporated Share Price

Insmed Incorporated Share Price

NASDAQ: INSM | Large Cap
$111.54
+$14.44 (14.87%) Last updated on 30 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Insmed Incorporated Stock Performance

Open
$109.00
Prev. Close
$97.11
Circuit Range
N/A
Day Range
$104.68 - $114.40
Year Range
$90.42 - $212.58
Volume
5,39,903
Average Traded
$110.72

Insmed Incorporated Share Price Today

As of 30 October 2026, Insmed Incorporated's share price is $111.54. The stock opened at $109.00, compared to its previous close of $97.11. During today's trading session, Insmed Incorporated's share price traded between $104.68 and $114.40, with an average price of $109.54. Over the past 52 weeks, the stock has recorded a high of $212.58 and a low of $90.42. In terms of performance, Insmed Incorporated's share price has declined by 18.22% over the last six months and is down 41.19% on a year-on-year basis.

Insmed Incorporated Share Price Chart

Line chart of the Insmed Incorporated price trend over the selected period. The price rose overall, ranging from 104.85 to 114.40, ending at 111.52.
$104.68$114.40
L
Show Current Price
H

Insmed Incorporated Stock Fundamentals & Key Indicators

Market Cap
$22.20B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.76
Revenue (TTM)
$606.42B
Return On Equity (TTM)
-83.39%
Profit Margin
-210.54%
Debt to Equity
0.79
Quarterly Earnings Growth YoY
96.42%

Insmed Incorporated Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$142.34$263.84$305.96$425.49
Net Profit-$370.02-$328.49-$163.56-$13.24
Net Profit Margin-259.96%-124.50%-53.46%-3.11%
Income ChangeN/A11.22%50.21%91.91%

Insmed Incorporated Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$245.36$305.21$363.71$606.42
Net Profit-$481.53-$749.57-$913.77-$1276.78
Net Profit Margin-196.25%-245.59%-251.24%-210.54%
Income ChangeN/A-55.66%-21.91%-39.73%

About Insmed Incorporated

Insmed Inc is a biopharmaceutical company. Its commercial portfolio and clinical pipeline are organized around three therapeutic areas: Respiratory, Immunology and Inflammation, and Neuro and Other Rare. The company's two commercial products, Arikayce and Brinsupri, are both part of the Respiratory therapeutic area. The firm's clinical-stage programs are TPIP, INS1148, brensocatib, and INS1201, focusing on different therapeutic areas. Additionally, Insmed's pre-clinical research programs encompass various technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue. Geographically, the company generates maximum revenue from the United States from the sale of its commercial products.

Insmed Incorporated Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$114.68
$111.69
-2.24%
Sep 2026
$121.89
$114.25
-5.87%
Aug 2026
$98.70
$121.39
+23.13%
Jul 2026
$107.09
$98.58
-7.52%
Jun 2026
$106.20
$106.61
-0.21%
May 2026
$135.91
$106.83
-21.67%
Apr 2026
$162.26
$136.38
-16.59%
Mar 2026
$147.10
$163.52
+9.51%
Feb 2026
$156.59
$149.32
-4.78%
Jan 2026
$176.01
$156.82
-9.91%
Dec 2025
$206.80
$174.08
-16.22%
Nov 2025
$187.49
$207.78
+9.55%

INSM Share Price FAQs